GO
Loading...

Array Biopharma CEO: Developing products ourselves

Friday, 27 Sep 2013 | 6:50 PM ET

Mad Money host Jim Cramer calls Array BioPharma a spec play. The company has 6 trials in phase 3 in progress. Its CEO Ron Squarer discusses its partnerships with big players including Novartis and Celgene.